FDA APPROVES FIBRO DRUG

FDA Approves First Drug for Fibromyalgia The FDA has approved pregabalin (Lyrica) for treating fibromyalgia.
The drug is the first treatment for the condition; it was approved in 2004 for use in diabetic peripheral neuropathy and postherpetic neuralgia. The expanded approval was based on two double-blind controlled trials involving about 1800 patients. Lyrica "reduces pain and improves daily functions for some patients," according to the FDA. The agency says that the drug's mechanism is unknown.
The manufacturer, Pfizer, has agreed to study use of the drug in children and breast-feeding women, according to the FDA.
The most common side effects are mild-to-moderate dizziness and sleepiness.
FDA report (Free)
Manufacturer' s press release (Free)